Sim&Cure
PrivateLast Round
Series A
Extension
Nov 28, 2025
Total Funding Raised
$16.88M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sim&Cure operates in Healthcare & Life Sciences and is based in Montpellier. Its latest recorded funding round was a Series A Extension round in November 2025.
Sim&Cure is a healthtech company that develops AI-driven digital twin software solutions to assist clinicians in the planning and personalization of endovascular treatments for cerebral aneurysms.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Medical AI, 3D Printing, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sim&Cure Comparables
Compare Sim&Cure with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ArteryFlow Technology | 89% | |
| Materialise | 79% | |
| Mentice AB | 77% |
For institutional investors. Book with your work email.
Sim&Cure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 28, 2025 | ||||
| Series A | Apr 23, 2019 | ||||
| Seed | Jun 21, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sim&Cure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sofilaro | Series A Extension |
| Elaia Partners | Series A, Series A Extension |
| Tudigo | Series A Extension |
| Holnest | Series A Extension |
| SWEN Capital Partners | Series A Extension |
| IT-Translation | Seed, Series A Extension, Series A |
| IRDI Soridec Gestion | Series A Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 403% MoM.
- Nov 28, 2025
$11M round led by Elaia Partners.
For institutional investors. Book with your work email.
Sim&Cure Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sim&Cure's valuation, stock price, and market status.
Is Sim&Cure a public or private company?
Sim&Cure is a private company.
What is the current stock price of Sim&Cure?
Sim&Cure is a private company, so its shares have no public market price. Caplight tracks Sim&Cure's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sim&Cure worth (valuation)?
Valuation information for Sim&Cure is not publicly available.
Can I buy Sim&Cure stock?
Sim&Cure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sim&Cure's last funding round?
Sim&Cure's most recent funding round was Series A Extension on November 28, 2025.
Who are the main investors in Sim&Cure?
Key investors in Sim&Cure include Elaia Partners, IT-Translation.
Will Sim&Cure IPO soon?
No public IPO plans have been announced for Sim&Cure.
How can I track Sim&Cure secondary market activity?
Caplight tracks bids, offers, and trades in Sim&Cure's shares on secondary markets.